Single-use Technology for Biopharmaceuticals Market Size, Share and Global Trend By Product Type (Equipment, Consumables), By End-user (Biopharmaceutical Manufacturer, Academic Clinical Research Institutes,Others) and Regional Forecast, 2024-2032
KEY MARKET INSIGHTS
In June 2017, Repligen Corporation announced its merger with Spectrum Inc. to expand its product offerings in single-use bioprocessing technology. Initially, the pharmaceutical companies relied on comparatively inflexible, hard-piped equipment, which included large bioreactors and tanks which were more susceptible to contamination requiring a great level of monitoring and control process. Elimination of the risk of contamination is one of the greatest challenge faced by biopharmaceutical companies.
The introduction of single-use technology helped to overcome this challenge and to improve operational efficiency. Single-use technology also referred to as disposables, are intended for single-time use. These objects are commonly made up of polyethylene, polycarbonate, cellulose acetate, ethylene vinyl acetate, and others. The adoption of single-use technology has enabled pharmaceutical manufacturers to save the cost of production and achieve higher yields.
To gain extensive insights into the market, Request for Customization
The improved flexibility and increased reliability of single-use have accelerated the development of new therapies and the research process. The greater adoption towards single-use technology by biopharmaceuticals industries is attributed to its advantages resulting in the manufacture of assured quality drugs.
The growth in global single-use technology for biopharmaceuticals market is being driven by the rapid adoption of single-use disposables in the healthcare environment as it prevents contamination and increasing need for upstream and downstream purification during manufacturing. Also, the rise in several pharmaceutical companies along with the increase in production to meet the growing healthcare demands is anticipated to aid the single-use technology for biopharmaceuticals market to flourish during the forecast years.
However, the strict and variability in government regulations regarding single-use technology in different countries is a major factor that can restrict the growth in global single-use technology for biopharmaceuticals market.
Key Players Covered
Some of the major companies that are present in the global single-use technology for biopharmaceuticals market are General Electric Company, Aber Instruments Ltd, K - hner AG, Robert Bosch Packaging Technology GmbH, Hamilton Medical, Merck KgaA, Terumo Corporation, GEMÜ Gruppe, Infors AG, Levitronix, and other players.
SEGMENTATION
SEGMENTATION | DETAILS |
By Product Type | · Equipment - Bioreactor - Storage units - Sensors - Chromatography systems - Others · Consumables - Tubing - Pipettes - Flasks - Filters - Cartridges - Connectors - Others |
By End-user | · Biopharmaceutical Manufacturer - CMOs & CROs - In-house Manufacturer · Academic & Clinical Research Institutes · Others |
By Geography | · North America (USA and Canada) · Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific) · Latin America (Brazil, Mexico and Rest of Latin America) · Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa) |
The equipment segment among the product types is anticipated to dominate the global single-use technology for biopharmaceutical market during the forecast period; owing to its higher adoption and its higher cost compared to the rest of the products.
Key Insights
- Regulatory overview for key countries
- Start-ups with their funding overview
- Overview of advancements in single-use technology for biopharmaceuticals market
- Key mergers and acquisitions
Regional Analysis
The global single-use technology for biopharmaceuticals market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In North America and Europe, the single-use technology for biopharmaceuticals market is projected to grow at a fast pace in the anticipated years due to the frequent new pharmaceutical product launches and increasing trend of strategic as well as research collaborations in pharmaceutical industries. Additionally, the stringent regulatory guidelines for bioprocessing is anticipated to increase the adoption of single-use technologies in these regions. The growth in single-use technology for biopharmaceuticals market in the Asia Pacific is likely to propel due to the presence of various upcoming pharmaceutical production plants and rapid acceptance to the use of disposables.
Key Industry Developments
- In April 2018, MilliporeSigma launched 3 new single-use technology products namely Mobius Power MIX 2500 mixer, Millipak final fill filter, and Pellicon capsule with Ultracel membrane filtration device.
- In September 2017, Pall Corporation. launched Allegro Single-Use Chromatography System that can be used in a flow range of 10 to 900 L/h.
- Ongoing
- 2023
- 2019-2022
Personalize this Research
- Granular Research on Specified Regions or Segments
- Companies Profiled based on User Requirement
- Broader Insights Pertaining to a Specific Segment or Region
- Breaking Down Competitive Landscape as per Your Requirement
- Other Specific Requirement on Customization
Healthcare Clients
